Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2013 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
KURA ONCOLOGY ORD | 35 | Q2 2024 | 10.5% |
XENCOR ORD | 28 | Q2 2024 | 12.6% |
PROTHENA ORD | 23 | Q2 2024 | 28.0% |
ASSEMBLY BIOSCIENCES ORD | 23 | Q3 2020 | 19.0% |
FIBROGEN ORD | 22 | Q1 2020 | 12.4% |
GALAPAGOS NV SPON ADR | 22 | Q2 2024 | 12.0% |
MORPHIC HOLDING ORD | 21 | Q2 2024 | 8.5% |
IRONWOOD PHARMA CL A ORD | 20 | Q1 2020 | 13.9% |
ANAPTYSBIO INC | 19 | Q2 2024 | 8.3% |
ARVINAS INC | 18 | Q2 2024 | 7.2% |
View EcoR1 Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
HOOKIPA Pharma Inc. | May 31, 2024 | 5,717,324 | 5.9% |
Morphic Holding, Inc. | May 03, 2024 | 3,014,752 | 6.0% |
LENZ Therapeutics, Inc. | April 08, 2024 | 1,219,774 | 4.8% |
Adaptimmune Therapeutics PLC | March 26, 2024 | 164,424,420 | 10.7% |
Crinetics Pharmaceuticals, Inc. | March 11, 2024 | 4,155,375 | 5.3% |
Zymeworks Inc. | February 22, 2024 | 14,132,291 | 20.0% |
iTeos Therapeutics, Inc. | February 16, 2024 | 1,944,672 | 5.4% |
ABEONA THERAPEUTICS INC. | February 14, 2024 | 1,086,956 | 4.2% |
Adicet Bio, Inc. | February 14, 2024 | ? | ? |
Aligos Therapeutics, Inc. | February 14, 2024 | 7,264,147 | 10.0% |
View EcoR1 Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-09-03 |
SC 13G | 2024-09-03 |
SC 13D | 2024-08-23 |
4 | 2024-08-16 |
SC 13D/A | 2024-08-16 |
13F-HR | 2024-08-14 |
SC 13G | 2024-07-01 |
SC 13G | 2024-05-31 |
13F-HR | 2024-05-15 |
SC 13G | 2024-05-03 |
View EcoR1 Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.